Marrow Fibrosis as a Risk Factor for Posttransplantation Outcome in Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with Multilineage Dysplasia
Open Access
- 1 March 2007
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 13 (3), 345-354
- https://doi.org/10.1016/j.bbmt.2006.10.030
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- A WHO Classification-Based Prognostic Scoring System (WPSS) for Predicting Survival in Myelodysplastic Syndromes.Blood, 2005
- Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantationBlood, 2003
- Myelodysplasia with fibrosis: a distinct entity?Leukemia Research, 2001
- The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institutionBritish Journal of Haematology, 1995
- Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsiesBlood, 1992
- Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative featuresAnnals of Hematology, 1991
- Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entityBritish Journal of Haematology, 1991
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Bone marrow histology in myelodysplastic syndromesBritish Journal of Haematology, 1984
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982